Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1

Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In vitro cellular & developmental biology. Animal 2018-05, Vol.54 (5), p.392-399
Hauptverfasser: Oyama, Rieko, Kito, Fusako, Sakumoto, Marimu, Shiozawa, Kumiko, Toki, Shunichi, Endo, Makoto, Yoshida, Akihiko, Kawai, Akira, Kondo, Tadashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 399
container_issue 5
container_start_page 392
container_title In vitro cellular & developmental biology. Animal
container_volume 54
creator Oyama, Rieko
Kito, Fusako
Sakumoto, Marimu
Shiozawa, Kumiko
Toki, Shunichi
Endo, Makoto
Yoshida, Akihiko
Kawai, Akira
Kondo, Tadashi
description Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.
doi_str_mv 10.1007/s11626-018-0237-7
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2022978417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26578099</jstor_id><sourcerecordid>26578099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-3678887e9427f9f6b136b98685171a28c0d6ecaf278cba9ee298aff79a37e0823</originalsourceid><addsrcrecordid>eNp9kEtLHEEUhQtRfEz8AS4MBdlkkTL1mKnHUhpjAhIXGsjK4nbNbe2hu8tU9QTMr7eGHiO4sDb3Qp1z7uEj5ETwM8G5-ZqF0FIzLizjUhlmdsihWMwVM1z_3i07N4JJ7fgBOcp5xctzQu-TA-mKTxp7SO4u8gh11-aHHoeRwrCkjymOGPs20PAACcKIqf0HYxsHGhsKdIh_saP5qcwWygIpxB5owK6jXTvgF_qzqtjNjWSV-ED2GugyHm_njPz6dnFbfWdX15c_qvMrFuaaj0xpY6016ObSNK7RtVC6dlbbhTACpA18qTFAUyqHGhyidBaaxjhQBrmVakY-T7ml_J815tH3bd40ggHjOnvJpXTGzoUp0k9vpKu4TkNp56VQ3BQ2ShWVmFQhxZwTNv4xtT2kJy-438D3E3xf4PsNfL9J_rhNXtc9Lv87XmgXgZwEuXwN95heT7-XejqZVnmM6TVUL4zlzqlnvGWXOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2130729633</pqid></control><display><type>article</type><title>Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1</title><source>JSTOR Archive Collection A-Z Listing</source><source>SpringerLink Journals - AutoHoldings</source><creator>Oyama, Rieko ; Kito, Fusako ; Sakumoto, Marimu ; Shiozawa, Kumiko ; Toki, Shunichi ; Endo, Makoto ; Yoshida, Akihiko ; Kawai, Akira ; Kondo, Tadashi</creator><creatorcontrib>Oyama, Rieko ; Kito, Fusako ; Sakumoto, Marimu ; Shiozawa, Kumiko ; Toki, Shunichi ; Endo, Makoto ; Yoshida, Akihiko ; Kawai, Akira ; Kondo, Tadashi</creatorcontrib><description>Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.</description><identifier>ISSN: 1071-2690</identifier><identifier>EISSN: 1543-706X</identifier><identifier>DOI: 10.1007/s11626-018-0237-7</identifier><identifier>PMID: 29626278</identifier><language>eng</language><publisher>New York: Springer Science &amp; Business Media LLC</publisher><subject>Animal Genetics and Genomics ; Biomedical and Life Sciences ; Cancer therapies ; Cell Biology ; Cell Culture ; Chemotherapy ; Deoxyribonucleic acid ; Developmental Biology ; DNA ; ESTABLISHMENT OF CELL LINES ; Fusion protein ; Gene expression ; Life Sciences ; Mass spectrometry ; Mass spectroscopy ; Medical prognosis ; Mesenchyme ; Patients ; Sarcoma ; Stem Cells ; Studies ; Synovial sarcoma ; Tissue culture ; Tissues ; Transfusion ; Tumors</subject><ispartof>In vitro cellular &amp; developmental biology. Animal, 2018-05, Vol.54 (5), p.392-399</ispartof><rights>2018 Society for In Vitro Biology</rights><rights>The Society for In Vitro Biology 2018</rights><rights>Copyright Society for In Vitro Biology May 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-3678887e9427f9f6b136b98685171a28c0d6ecaf278cba9ee298aff79a37e0823</citedby><cites>FETCH-LOGICAL-c460t-3678887e9427f9f6b136b98685171a28c0d6ecaf278cba9ee298aff79a37e0823</cites><orcidid>0000-0001-6405-7792</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/26578099$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/26578099$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,41488,42557,51319,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29626278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oyama, Rieko</creatorcontrib><creatorcontrib>Kito, Fusako</creatorcontrib><creatorcontrib>Sakumoto, Marimu</creatorcontrib><creatorcontrib>Shiozawa, Kumiko</creatorcontrib><creatorcontrib>Toki, Shunichi</creatorcontrib><creatorcontrib>Endo, Makoto</creatorcontrib><creatorcontrib>Yoshida, Akihiko</creatorcontrib><creatorcontrib>Kawai, Akira</creatorcontrib><creatorcontrib>Kondo, Tadashi</creatorcontrib><title>Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1</title><title>In vitro cellular &amp; developmental biology. Animal</title><addtitle>In Vitro Cell.Dev.Biol.-Animal</addtitle><addtitle>In Vitro Cell Dev Biol Anim</addtitle><description>Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.</description><subject>Animal Genetics and Genomics</subject><subject>Biomedical and Life Sciences</subject><subject>Cancer therapies</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Chemotherapy</subject><subject>Deoxyribonucleic acid</subject><subject>Developmental Biology</subject><subject>DNA</subject><subject>ESTABLISHMENT OF CELL LINES</subject><subject>Fusion protein</subject><subject>Gene expression</subject><subject>Life Sciences</subject><subject>Mass spectrometry</subject><subject>Mass spectroscopy</subject><subject>Medical prognosis</subject><subject>Mesenchyme</subject><subject>Patients</subject><subject>Sarcoma</subject><subject>Stem Cells</subject><subject>Studies</subject><subject>Synovial sarcoma</subject><subject>Tissue culture</subject><subject>Tissues</subject><subject>Transfusion</subject><subject>Tumors</subject><issn>1071-2690</issn><issn>1543-706X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kEtLHEEUhQtRfEz8AS4MBdlkkTL1mKnHUhpjAhIXGsjK4nbNbe2hu8tU9QTMr7eGHiO4sDb3Qp1z7uEj5ETwM8G5-ZqF0FIzLizjUhlmdsihWMwVM1z_3i07N4JJ7fgBOcp5xctzQu-TA-mKTxp7SO4u8gh11-aHHoeRwrCkjymOGPs20PAACcKIqf0HYxsHGhsKdIh_saP5qcwWygIpxB5owK6jXTvgF_qzqtjNjWSV-ED2GugyHm_njPz6dnFbfWdX15c_qvMrFuaaj0xpY6016ObSNK7RtVC6dlbbhTACpA18qTFAUyqHGhyidBaaxjhQBrmVakY-T7ml_J815tH3bd40ggHjOnvJpXTGzoUp0k9vpKu4TkNp56VQ3BQ2ShWVmFQhxZwTNv4xtT2kJy-438D3E3xf4PsNfL9J_rhNXtc9Lv87XmgXgZwEuXwN95heT7-XejqZVnmM6TVUL4zlzqlnvGWXOQ</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Oyama, Rieko</creator><creator>Kito, Fusako</creator><creator>Sakumoto, Marimu</creator><creator>Shiozawa, Kumiko</creator><creator>Toki, Shunichi</creator><creator>Endo, Makoto</creator><creator>Yoshida, Akihiko</creator><creator>Kawai, Akira</creator><creator>Kondo, Tadashi</creator><general>Springer Science &amp; Business Media LLC</general><general>Springer US</general><general>Society for In Vitro Biology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7QL</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6405-7792</orcidid></search><sort><creationdate>20180501</creationdate><title>Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1</title><author>Oyama, Rieko ; Kito, Fusako ; Sakumoto, Marimu ; Shiozawa, Kumiko ; Toki, Shunichi ; Endo, Makoto ; Yoshida, Akihiko ; Kawai, Akira ; Kondo, Tadashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-3678887e9427f9f6b136b98685171a28c0d6ecaf278cba9ee298aff79a37e0823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animal Genetics and Genomics</topic><topic>Biomedical and Life Sciences</topic><topic>Cancer therapies</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Chemotherapy</topic><topic>Deoxyribonucleic acid</topic><topic>Developmental Biology</topic><topic>DNA</topic><topic>ESTABLISHMENT OF CELL LINES</topic><topic>Fusion protein</topic><topic>Gene expression</topic><topic>Life Sciences</topic><topic>Mass spectrometry</topic><topic>Mass spectroscopy</topic><topic>Medical prognosis</topic><topic>Mesenchyme</topic><topic>Patients</topic><topic>Sarcoma</topic><topic>Stem Cells</topic><topic>Studies</topic><topic>Synovial sarcoma</topic><topic>Tissue culture</topic><topic>Tissues</topic><topic>Transfusion</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oyama, Rieko</creatorcontrib><creatorcontrib>Kito, Fusako</creatorcontrib><creatorcontrib>Sakumoto, Marimu</creatorcontrib><creatorcontrib>Shiozawa, Kumiko</creatorcontrib><creatorcontrib>Toki, Shunichi</creatorcontrib><creatorcontrib>Endo, Makoto</creatorcontrib><creatorcontrib>Yoshida, Akihiko</creatorcontrib><creatorcontrib>Kawai, Akira</creatorcontrib><creatorcontrib>Kondo, Tadashi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>In vitro cellular &amp; developmental biology. Animal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oyama, Rieko</au><au>Kito, Fusako</au><au>Sakumoto, Marimu</au><au>Shiozawa, Kumiko</au><au>Toki, Shunichi</au><au>Endo, Makoto</au><au>Yoshida, Akihiko</au><au>Kawai, Akira</au><au>Kondo, Tadashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1</atitle><jtitle>In vitro cellular &amp; developmental biology. Animal</jtitle><stitle>In Vitro Cell.Dev.Biol.-Animal</stitle><addtitle>In Vitro Cell Dev Biol Anim</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>54</volume><issue>5</issue><spage>392</spage><epage>399</epage><pages>392-399</pages><issn>1071-2690</issn><eissn>1543-706X</eissn><abstract>Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.</abstract><cop>New York</cop><pub>Springer Science &amp; Business Media LLC</pub><pmid>29626278</pmid><doi>10.1007/s11626-018-0237-7</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6405-7792</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1071-2690
ispartof In vitro cellular & developmental biology. Animal, 2018-05, Vol.54 (5), p.392-399
issn 1071-2690
1543-706X
language eng
recordid cdi_proquest_miscellaneous_2022978417
source JSTOR Archive Collection A-Z Listing; SpringerLink Journals - AutoHoldings
subjects Animal Genetics and Genomics
Biomedical and Life Sciences
Cancer therapies
Cell Biology
Cell Culture
Chemotherapy
Deoxyribonucleic acid
Developmental Biology
DNA
ESTABLISHMENT OF CELL LINES
Fusion protein
Gene expression
Life Sciences
Mass spectrometry
Mass spectroscopy
Medical prognosis
Mesenchyme
Patients
Sarcoma
Stem Cells
Studies
Synovial sarcoma
Tissue culture
Tissues
Transfusion
Tumors
title Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A45%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Establishment%20and%20proteomic%20characterization%20of%20a%20novel%20synovial%20sarcoma%20cell%20line,%20NCC-SS2-C1&rft.jtitle=In%20vitro%20cellular%20&%20developmental%20biology.%20Animal&rft.au=Oyama,%20Rieko&rft.date=2018-05-01&rft.volume=54&rft.issue=5&rft.spage=392&rft.epage=399&rft.pages=392-399&rft.issn=1071-2690&rft.eissn=1543-706X&rft_id=info:doi/10.1007/s11626-018-0237-7&rft_dat=%3Cjstor_proqu%3E26578099%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2130729633&rft_id=info:pmid/29626278&rft_jstor_id=26578099&rfr_iscdi=true